Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in Canada
Health Canada is issuing this guidance for clinical trials in type 2 diabetes to provide clarification on the interpretation of the Canadian Diabetes Association Clinical Practice Guidelines (CDA-CPG)Footnote1 in relation to clinical trial applications under Part C, Division 5 of the Food and Drug Regulations.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in CanadaHTMLEnglish publication HTML
-
Guidance for Industry: Standards for Clinical Trials in Type 2 Diabetes in CanadaHTMLFrench publication HTML
Similar records